T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.81B |
| 2 |
XYZ
Block Inc
XYZ
|
+$1.46B |
| 3 |
Accenture
ACN
|
+$1.23B |
| 4 |
Gilead Sciences
GILD
|
+$1.15B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.61B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.06B |
| 3 |
Tesla
TSLA
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.72B |
| 5 |
Amazon
AMZN
|
+$1.59B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.44% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.3% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRA
1851
DELISTED
ProAssurance
PRA
| $1.2M | ﹤0.01% |
51,436
+2,281
| +5% | +$36.9K |
|
1852
Nutrien
NTR
$32.5B
| $1.2M | ﹤0.01% |
24,074
+83
| +0.3% | +$4.25K |
|
1853
Greif
GEF
$4.98B
| $1.19M | ﹤0.01% |
21,650
+1,020
| +5% | +$60.1K |
|
1854
Arrowhead Research
ARWR
$11.9B
| $1.19M | ﹤0.01% |
93,189
+17,331
| +23% | +$315K |
|
1855
Customers Bancorp
CUBI
$2.82B
| $1.19M | ﹤0.01% |
23,626
+1,906
| +9% | +$100K |
|
1856
Recursion Pharmaceuticals
RXRX
$1.69B
| $1.19M | ﹤0.01% |
224,234
+92,244
| +70% | +$672K |
|
1857
Carter's
CRI
$1.43B
| $1.19M | ﹤0.01% |
28,979
+2,067
| +8% | +$99.4K |
|
1858
NETSCOUT
NTCT
$2.89B
| $1.18M | ﹤0.01% |
56,132
+2,825
| +5% | +$63.5K |
|
|
AVDX
1859
DELISTED
AvidXchange
AVDX
| $1.18M | ﹤0.01% |
138,837
+16,275
| +13% | +$150K |
|
|
DMC
1860
Del Monte Corp
DMC
$1.44B
| $1.18M | ﹤0.01% |
38,143
+1,253
| +3% | +$38.5K |
|
1861
Hope Bancorp
HOPE
$1.86B
| $1.18M | ﹤0.01% |
112,144
+3,957
| +4% | +$44.4K |
|
1862
Playtika
PLTK
$946M
| $1.17M | ﹤0.01% |
226,574
+22,721
| +11% | +$143K |
|
1863
Pediatrix Medical
MD
$2.13B
| $1.17M | ﹤0.01% |
80,585
+3,192
| +4% | +$45.3K |
|
1864
Upbound Group
UPBD
$1.15B
| $1.16M | ﹤0.01% |
48,451
-19,439
| -29% | -$534K |
|
1865
Hilltop Holdings
HTH
$2.29B
| $1.16M | ﹤0.01% |
37,982
+1,508
| +4% | +$45.8K |
|
1866
D-Wave Quantum Inc. Common Stock
QBTS
$7.81B
| $1.16M | ﹤0.01% |
152,203
+113,933
| +298% | +$765K |
|
|
THS
1867
DELISTED
Treehouse Foods
THS
| $1.15M | ﹤0.01% |
42,431
+1,995
| +5% | +$63.2K |
|
1868
FB Financial Corp
FBK
$3.1B
| $1.15M | ﹤0.01% |
24,780
+3,487
| +16% | +$175K |
|
1869
Novavax
NVAX
$1.32B
| $1.15M | ﹤0.01% |
179,137
+99,073
| +124% | +$819K |
|
1870
Burford Capital
BUR
$979M
| $1.15M | ﹤0.01% |
86,624
+7,125
| +9% | +$100K |
|
1871
LGI Homes
LGIH
$1.37B
| $1.15M | ﹤0.01% |
17,215
+1,688
| +11% | +$136K |
|
|
WNS
1872
DELISTED
WNS Holdings
WNS
| $1.14M | ﹤0.01% |
18,592
+1,686
| +10% | +$96.2K |
|
1873
Sprout Social
SPT
$597M
| $1.14M | ﹤0.01% |
51,850
+7,065
| +16% | +$205K |
|
1874
Barings BDC
BBDC
$982M
| $1.14M | ﹤0.01% |
119,339
-192,203
| -62% | -$1.9M |
|
1875
Sotera Health
SHC
$5.4B
| $1.14M | ﹤0.01% |
97,578
+7,910
| +9% | +$102K |
|
Similar funds
T. Rowe Price Associates's Q1 2025 Portfolio in Review
As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
- T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
- T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
- T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
- T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
- T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.
Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.